Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology

5 Jul 2011

Abstract excerpt

BACKGROUND: Fluorescence in situ hybridization (FISH) is routinely used to help clarify atypical urinary cytology. However, to the authors' knowledge, little is known regarding the frequency of chromosomal aberrations in non-neoplastic conditions that could potentially lead to false-positive FISH results. The objective of the current study was to evaluate the frequency of chromosomal aberrations in benign cells...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Genomic variations and chromosomal abnormalities
Share to Pediatric Urology and Nephrology Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21732550
DOI: 10.1002/cncy.20171

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytologyPMID 21732550Read ↗

Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right CatchSemantic proximity Read ↗

Fluorescence in situ hybridization for detecting urothelial carcinomaSemantic proximity Read ↗

Fluorescence-in-situ-hybridization in the Surveillance of Urothelial Cancers: Can Use of Cystoscopy or Ureteroscopy be Deferred?Semantic proximity Read ↗

Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerSemantic proximity Read ↗

Chromosomal changes in uroepithelial carcinomasSemantic proximity Read ↗

Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancerSemantic proximity Read ↗

Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinomaSemantic proximity Read ↗

Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urotheliumSemantic proximity Read ↗

Quantitative molecular urinary cytology by fluorescence <i>in situ</i> hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?Semantic proximity Read ↗

Centrosomal abnormality is common in and a potential biomarker for bladder cancerSemantic proximity Read ↗

Bladder Cancer Detection Using FISH (UroVysion Assay)Semantic proximity Read ↗

Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.